Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05697380 · ClinicalTrials.gov registry record · NA
CB3 Pilot (Communication Bridge: A Person-centered Internet-based Intervention for Individuals With Primary Progressive Aphasia)
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT05697380 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 8 participants.
The verdict
NCT05697380, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
This study will evaluate evidence-based treatments for adults with mild Primary Progressive Aphasia (PPA). The aim of the study is to help identify efficacious communication and quality of life interventions for those with PPA and their care-partners. Participants with a diagnosis of PPA and their actively-engaged care partners will be involved in the study for 12 months. Each participant will receive a iPad equipped with the necessary applications and features for the study. Participants will complete evaluations, speech therapy sessions with a speech and language therapist, and sessions with a licensed social worker or related clinician. They will have access to Communication Bridge, a personalized web application to practice home exercises that reinforce treatment strategies. There are no costs to participate in this study.
Interventions
- BEHAVIORAL Communication Bridge™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2023-07-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05697380
The ClinicalTrials.gov registry entry for NCT05697380 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Communication Bridge™ is the first listed.
NCT05697380 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05697380 about?
NCT05697380 is a clinical study titled "CB3 Pilot (Communication Bridge: A Person-centered Internet-based Intervention for Individuals With Primary Progressive Aphasia)". This study will evaluate evidence-based treatments for adults with mild Primary Progressive Aphasia (PPA). The aim of the study is to help identify efficacious communication and quality of life interventions for those with PPA and their care-partners. Participants with a diagnosis of PPA and their ...
What is the current status of trial NCT05697380?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2021-06-01. Estimated completion is 2023-07-12.
What interventions are being tested in trial NCT05697380?
The interventions under investigation include: Communication Bridge™ (BEHAVIORAL).
Who is sponsoring clinical trial NCT05697380?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.